Different mortality time points in critical care trials: current practice and influence on effect estimates in meta-analyses

Critical Care Medicine

Volumn 44, Issue 8, 2016, Pages e737-e741

  Roth, Dominik ^a   Heidinger, Benedikt ^a   Havel, Christof ^a   Herkner, Harald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

critical care; meta analysis as topic; mortality

Indexed keywords

FOLLOW UP; FUNDING; HUMAN; INTENSIVE CARE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; META ANALYSIS (TOPIC); METHODOLOGY; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

CRITICAL CARE; HUMANS; META-ANALYSIS AS TOPIC; MORTALITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TIME FACTORS;

EID: 84960453211     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001631     Document Type: Review

References (12)

1. Taori G, Ho KM, George C, et al. Landmark survival as an end-point for trials in critically ill patients-comparison of alternative durations of follow-up: An exploratory analysis. Crit Care 2009; 13: R128
2. Williams TA, Dobb GJ, Finn JC, et al. Data linkage enables evaluation of long-Term survival after intensive care. Anaesth Intensive Care 2006; 34: 307-315
3. Williams TA, Dobb GJ, Finn JC, et al. Determinants of long-Term survival after intensive care. Crit Care Med 2008; 36: 1523-1530
4. Wright JC, Plenderleith L, Ridley SA. Long-Term survival following intensive care: Subgroup analysis and comparison with the general population. Anaesthesia 2003; 58: 637-642
5. Wolkewitz M, Beyersmann J, Gastmeier P, et al. Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 2009; 35: 826-832
6. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-Analyses. In. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). Higgins JPT, Green S (Eds) the Cochrane Collaboration, 2011. Available at. http://www.cochrane-handbook.org. Accessed March 1, 2016
7. Bernard GR, Vincent JL, Laterre PF, et al; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
8. Wheeler AP, Bernard GR, Thompson BT. Pulmonary-Artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006, 354: 2213-2224
9. Steinberg KP, Hudson LD, Goodman RB, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671-1684
10. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461
11. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome the Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342: 1301-1308
12. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE. In. Fourth International Cochrane Colloquium. Adelaide, Australia, 1996